[Treatment patterns in advanced breast cancer with anthracycline and taxanes and their costs in three public hospitals of Mexico].

Objectives: In Mexico, breast cancer is the second leading cause of cancer mortality among females. For patients with advanced breast cancer (ABC) resistant to anthracyclines and taxanes (AT), there are limited treatment options. There is a scarcity of data regarding clinical management of this population and treatment costs at this stage of the disease.